Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 9M2R7 | — |
expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 9M2R7, expiry date 31-DEC-2025) for prophylaxis. On 05-JAN-2026, the patient received Menveo. On 05-JAN-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 06-JAN-2026 Reporter stated that a dose of Menveo 1-vial presentation with expiration date of 31-DEC-2025 was given to a patient.